Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-08

FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for escitalopram oxalate (escitalopram) by Sun Pharmaceutical Industries, enabling marketing of the generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)